home / stock / glpgf / glpgf news


GLPGF News and Press, Galapagos Genomics Ord From 10/10/22

Stock Information

Company Name: Galapagos Genomics Ord
Stock Symbol: GLPGF
Market: OTC
Website: glpg.com

Menu

GLPGF GLPGF Quote GLPGF Short GLPGF News GLPGF Articles GLPGF Message Board
Get GLPGF Alerts

News, Short Squeeze, Breakout and More Instantly...

GLPGF - Tracking David Einhorn's Greenlight Capital Portfolio - Q2 2022 Update

Summary David Einhorn's 13F stock portfolio value decreased from $1.57B to $1.29B this quarter. Greenlight increased Atlas Air Worldwide, Kyndryl Holdings, and Victoria’s Secret while decreasing Teck Resources, Change Healthcare, Chemours, and International Seaways. They al...

GLPGF - Galapagos receives transparency notification from FMR

Galapagos ( OTCPK:GLPGF ) received a transparency notification from FMR LLC, who notified that it holds 3,710,782 of Galapagos’ voting rights. FMR controls investment funds Fidelity Management & Research Company, FIAM Holdings, Fidelity Management Trust Company and ...

GLPGF - Galapagos NV (GLPG) CEO Paul Stoffels on Q2 2022 Results - Earnings Call Transcript

Galapagos NV (GLPG) Q2 2022 Earnings Conference Call August 5, 2022 08:00 ET Company Participants Sofie Van Gijsel - Senior Director of Investor Relations Paul Stoffels - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer ...

GLPGF - Galapagos to enter cell therapy space with acquisition of CellPoint and AboundBio

Mechelen, Belgium-based biotech Galapagos (NASDAQ:GLPG) (OTC:GLPGF) has agreed to acquire CellPoint, a privately held developer of point-of-care CAR-T therapies and AboundBio, a developer of antibody-based biological therapeutics for cancers. Per the terms, Galapagos (GLPG) is expected to acq...

GLPGF - Takeda Pharmaceutical Vs. Gilead Sciences: Who Is The Dividend King?

Takeda's total debt was $35,698.6 million, down 22.1% from the previous year. Takeda Pharmaceutical has a dividend yield of 5.15%, and Gilead Sciences has a dividend yield of 4.53%. Gilead's key HIV drug is beginning to feel increased competition from ViiV Healthcare's drug. T...

GLPGF - Morgan Stanley updates biotechs with negative enterprise values & 2022 catalysts

Reviewing its coverage on biotechs with negative enterprise values, Morgan Stanley says that the number of companies on the list with potential catalysts in 2022 has increased to 27 in May from 20 previously. Adding market capitalization to total debt and deducting cash and cash equivalents, ...

GLPGF - Tracking David Einhorn's Greenlight Capital Portfolio - Q1 2022 Update

David Einhorn's 13F stock portfolio value decreased from $1.75B to $1.57B this quarter. Greenlight increased Chemours, Warner Bros. Discovery, Resideo, LivaNova, Kyndryl, and PLBY while dropping Jack in the Box and EchoStar. They also added Southwestern Energy, Weatherford plc, Intern...

GLPGF - Galapagos NV 2022 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Galapagos NV in conjunction with their 2022 Q1 earnings call. For further details see: Galapagos NV 2022 Q1 - Results - Earnings Call Presentation

GLPGF - Galapagos NV (GLPG) CEO Paul Stoffels on Q1 2022 Results - Earnings Call Transcript

Galapagos NV (GLPG) Q1 2022 Results Conference Call May 6, 2022 08:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Paul Stoffels - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief Medical Of...

GLPGF - Tracking David Einhorn's Greenlight Capital Portfolio - Q4 2021 Update

David Einhorn's 13F stock portfolio value increased from $1.49B to $1.75B this quarter. Greenlight increased Capri Holdings, ODP Group, Livanova, & Victoria’s Secret while reducing Twitter, Concentrix, & EchoStar. They also added Global Payments while dropping AerCap an...

Previous 10 Next 10